Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4935263 | Seizure | 2017 | 8 Pages |
Abstract
ATN DBS can be an effective therapy in a variety of patients with DRE. Importantly, we provide evidence that significant therapeutic efficacy can be sustained for up to 11 years. Neurological complications were rather rare, but long-term hardware-related complications should be followed arrectis auribus.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Seong Hoon Kim, Sung Chul Lim, Jiyeon Kim, Byung-Chul Son, Kyung Jin Lee, Young-Min Shon,